相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Downregulation of Hsp27 (HSPB1) in MCF-7 human breast cancer cells induces upregulation of PTEN
Niubys Cayado-Gutierrez et al.
CELL STRESS & CHAPERONES (2013)
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
Jonathan T. Sims et al.
PLOS ONE (2013)
Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo
Keqiang Zuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Sulphoraphane, a naturally occurring isothiocyanate induces apoptosis in breast cancer cells by targeting heat shock proteins
Ruma Sarkar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells
Shin-Ae Kang et al.
BIOCHEMICAL JOURNAL (2012)
Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells
Che-Hsin Lee et al.
BIOCHIMIE (2012)
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M. Gartner et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies
Cynthie Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors
Abdulateef O. Aregbe et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors
Komal Jhaveri et al.
CLINICAL CANCER RESEARCH (2012)
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression
Ramona Schulz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion
Avraam El Hamidieh et al.
PLOS ONE (2012)
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
Oddbjorn Straume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HSP90 inhibitor antagonizing MIF The specifics of pleiotropic cancer drug candidates
Ramona Schulz et al.
ONCOIMMUNOLOGY (2012)
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng et al.
BREAST CANCER RESEARCH (2012)
Hsp90α/β associates with the GSK3β/axin1/phospho-β-catenin complex in the human MCF-7 epithelial breast cancer model
Leanne C. Cooper et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Design, synthesis, and evaluation of small molecule Hsp90 probes
Tony Taldone et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Shanu Modi et al.
CLINICAL CANCER RESEARCH (2011)
Heat Shock Protein as Molecular Targets for Breast Cancer Therapeutics
Lee Su Kim et al.
JOURNAL OF BREAST CANCER (2011)
Extracellular Heat Shock Protein (Hsp) 70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion
Jessica D. Sims et al.
PLOS ONE (2011)
Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappa B
Li Wei et al.
BREAST CANCER RESEARCH (2011)
N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine
Nafiseh Pakravan et al.
CELL STRESS & CHAPERONES (2010)
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
Se Hun Kang et al.
BMC CANCER (2008)
Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent
Nina Marie Pedersen et al.
MOLECULAR CANCER RESEARCH (2008)
High HSP90 expression is associated with decreased survival in breast cancer
Elah Pick et al.
CANCER RESEARCH (2007)
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer
Grzegorz S. Nowakowski et al.
CLINICAL CANCER RESEARCH (2006)
Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation
KD Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Enhanced immunity by NeuEDhsp70 DNA vaccine is needed to combat an aggressive spontaneous metastatic breast cancer
JH Kim et al.
MOLECULAR THERAPY (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27
PA O'Neill et al.
BRITISH JOURNAL OF CANCER (2004)
Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines
H Hauser et al.
GENE THERAPY (2004)
Disassembly of transcriptional regulatory complexes by molecular chaperones
BC Freeman et al.
SCIENCE (2002)
Hsp90 as a capacitor of phenotypic variation
C Queitsch et al.
NATURE (2002)
Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines
R Mandler et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2
J Nylandsted et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
